Pyrazine derivatives as phosphatidylinositol 3-kinase inhibitors
US9862711B2 · kind B2 · utility
0Cited by
0References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 24, 2014 |
| Grant date | Jan 9, 2018 |
| Priority date | — |
| Expiry date | Apr 24, 2034 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D409/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides compounds of formula (I) which inhibit the activity of PI 3-kinase gamma isoform, which are useful for the treatment of diseases mediated by the activation of PI 3-kinase gamma isoform.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.